Advertisement

Adamas Pharmaceuticals, Inc. ADMS

Set alert

Price alert · ADMS

All alert types
8.22 0.00 0.00%

As of Apr 24, 3:47 PM ET

8.18 Day range 8.25

52-week range unavailable

Open
8.24
Prev close
8.22
Mkt cap
376.37M
Vol
3.15M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
8.18
High
8.25
Forward P/E
-22.22
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Nov 10, 2021
50-d avg
7.00
200-d avg
5.54
1y target
8.52

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ADMS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Product → Revenue: $24.58MRevenue → Gross Profit: $25.32MGross Profit → Expenses: $25.32MRevenue → Cost of Revenue: $576.00KExpenses → Selling, General & Admin: $29.73MExpenses → Research & Development: $1.23MExpenses → Interest Expense: $13.88MRoyalty → Revenue: $1.32MNet Loss → Expenses: $19.52MGross Profit$25.32MNet Loss$19.52MCost of Revenue$576.00KExpenses$44.84MSelling, General & Admin$29.73MResearch & Development$1.23MInterest Expense$13.88MRevenue$25.90MProduct$24.58MRoyalty$1.32M

Period ending Sep 30, 2021 · select a line to chart its history

Income statement

ADMS quarterly income statement
25.90M
25.90M
576.00K
25.32M
30.96M
1.23M
29.73M
-5.64M
3.50M
-19.52M
-19.52M
-19.52M
-19.52M
-0.43
-0.43
-0.43
-16.02M
-16.02M
45.62M
45.62M

Balance sheet

ADMS quarterly balance sheet
78.62M
78.62M
32.47M
4.47M
27.99M
10.05M
108.00M
6.86M
143.98M
4.55M
134.14M
23.84M
129.58M
165.58M
-549.72M
13.00K
-21.61M
-21.61M
35.98M
134.14M
687.00K
8.68M
141.74M
4.21M

Cash flow

ADMS quarterly cash flow
134.00K
-921.00K
-10.17M
-8.00K
34.00K
-955.00K
-3.01M
-3.00M
-6.25M
1.87M
Advertisement